Shahram Taeb
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shahram Taeb has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Davoud Rostamzadeh
Medicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, Iran
25 shared publications - Sahar Mafi
Department of Clinical Biochemistry, Yasuj University of Medical Sciences, Yasuj, Iran
25 shared publications - Bayan Mafakheri Bashmagh
Department of Biological Sciences, Faculty of Basic Science, University of Kurdistan, Sanandaj, Iran
24 shared publications - Behzad Mansoori
Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, PA 19104, USA
24 shared publications - Catharina Chiari
Department of Pediatric Orthopaedics and Foot Surgery, Orthopaedic Hospital Speising, Speisinger Strasse 109, 1130 Vienna, Austria
24 shared publications - Eileen Meehan
Department of Immunology, School of Medicine, University of Connecticut Health Center, Farmington, CT 06030, USA
24 shared publications
Latest Publications
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Fig. S2 from The mTOR Signaling Pathway Interacts with the ER Stress Response and the Unfolded Protein Response in Cancer
Supplementary Fig. S2. Endoplasmic reticulum stress and unfolded protein response in normal physiology and cancer Tumor cells frequently encounter endogenous and exogenous stresses that influence protein folding in the ER, including hypoxia, inflammation, nutrient deprivation, altered glycolysis, DNA damage, genomic instability, oncogene activation, and proteasome dysfunction, can cause excessive accumulation of misfolded or unfolded proteins within the ER lumen, a condition termed "ER stress." As a response to prolonged ER stress conditions, the ER responds to the ER stress by activating intracellular signal transduction pathways, collectively referred to as the UPR, to restore-ER homeostasis (protective effect) or activate cell death (cytotoxic effect). The UPR signaling cascade comprises three parallel pathways that employ unique signal transduction mechanisms and are initiated by activating three conserved ER-stress sensors: IRE1, ATF6, and PERK. Furthermore, in mammals and under resting conditions, the critical ER-resident chaperone, GRP78/BiP, prevents the activation and blocks the downstream signaling of UPR by binding to the N-terminal side of stress sensor proteins, IRE-1, PERK, and ATF6 and maintains these sensors in an inactive state. When ER stress is triggered, and the ER luminal load of unfolded or misfolded proteins increases, the GRP78/BiP dissociates, activating IRE1, PERK, and ATF6 signaling cascades, leading to the activation of these UPR signaling pathways. Upon activation, the UPR can regulate many cellular events of tumor cells, including autophagy, ER biogenesis, cell survival, metastasis, angiogenesis, migration and invasion, chemoresistance, glycolysis, and proliferation. ER, Endoplasmic reticulum; UPR, unfolded protein response; PREK, protein kinase R (PKR) like endoplasmic reticulum kinase; ATF, activating transcription factor; IRE1, inositol requiring enzyme 1; GRP78, 78-kDa glucose-regulated protein/immunoglobulin-binding protein; CHOP, C/EBP homologous protein; AMPK, AMP-activated protein kinase; XBP1, X-box binding protein 1; Dr5, death receptor 5; GADD34, growth arrest and DNA damage-inducible protein 34; ERO1α, ER oxidoreductin 1; GCN2, general control non-derepressible 2.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig. S2 from The mTOR Signaling Pathway Interacts with the ER Stress Response and the Unfolded Protein Response in Cancer
Supplementary Fig. S2. Endoplasmic reticulum stress and unfolded protein response in normal physiology and cancer Tumor cells frequently encounter endogenous and exogenous stresses that influence protein folding in the ER, including hypoxia, inflammation, nutrient deprivation, altered glycolysis, DNA damage, genomic instability, oncogene activation, and proteasome dysfunction, can cause excessive accumulation of misfolded or unfolded proteins within the ER lumen, a condition termed "ER stress." As a response to prolonged ER stress conditions, the ER responds to the ER stress by activating intracellular signal transduction pathways, collectively referred to as the UPR, to restore-ER homeostasis (protective effect) or activate cell death (cytotoxic effect). The UPR signaling cascade comprises three parallel pathways that employ unique signal transduction mechanisms and are initiated by activating three conserved ER-stress sensors: IRE1, ATF6, and PERK. Furthermore, in mammals and under resting conditions, the critical ER-resident chaperone, GRP78/BiP, prevents the activation and blocks the downstream signaling of UPR by binding to the N-terminal side of stress sensor proteins, IRE-1, PERK, and ATF6 and maintains these sensors in an inactive state. When ER stress is triggered, and the ER luminal load of unfolded or misfolded proteins increases, the GRP78/BiP dissociates, activating IRE1, PERK, and ATF6 signaling cascades, leading to the activation of these UPR signaling pathways. Upon activation, the UPR can regulate many cellular events of tumor cells, including autophagy, ER biogenesis, cell survival, metastasis, angiogenesis, migration and invasion, chemoresistance, glycolysis, and proliferation. ER, Endoplasmic reticulum; UPR, unfolded protein response; PREK, protein kinase R (PKR) like endoplasmic reticulum kinase; ATF, activating transcription factor; IRE1, inositol requiring enzyme 1; GRP78, 78-kDa glucose-regulated protein/immunoglobulin-binding protein; CHOP, C/EBP homologous protein; AMPK, AMP-activated protein kinase; XBP1, X-box binding protein 1; Dr5, death receptor 5; GADD34, growth arrest and DNA damage-inducible protein 34; ERO1α, ER oxidoreductin 1; GCN2, general control non-derepressible 2.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Fig. S1 from The mTOR Signaling Pathway Interacts with the ER Stress Response and the Unfolded Protein Response in Cancer
Supplementary Fig. S1. The structure of mTOR complexes and overview of the PI3K/AKT/mTOR signaling pathway. The mTOR signaling pathway is implicated in a variety of major cellular processes, from cell growth to apoptosis. mTOR nucleates at least two distinct multi-protein complexes, mTORC1 and mTORC2. mTORC1 activation occurs in the response of growth factors through PI3K/Akt and RAS/MAPK pathways. Human mTOR can assemble at least two larges, physically, and functionally distinct polyprotein complexes, mTORC1, and mTORC2. mTORC1 and mTORC2 share several common proteins, including the catalytic subunit mTOR, mLST8 and DEPTOR, and Tel2/Tti1 complex. In addition, each complex has specific proteins. The activity of mTORC1 is regulated by multiple signals, including nutrient availability such as amino acids (leucine, arginine, and glutamine), intracellular energy level (Low ATP/High AMP), and extracellular growth factors such as insulin and cytokine receptors. A receptor-mediated activation of PI3K leads to PIP3 being produced from PIP2. PIP3 then promoted the recruitment of PDK1, AKT, and mTORC2 complex, facilitating the phosphorylation and full activation of AKT at Thr308 and Ser473 via PDK1 and mTORC2, respectively. Activated AKT phosphorylates TSC2 and induces the dissociation of TSC1 and TSC2 complex, which results in the dissociation of TSC2 from lysosomes and loss of their inhibitory action on RHEB/mTORC1 axis. Upon activation, mTOC1 promotes basic cellular events, including Cap-dependent translation, fatty acid synthesis, nucleoid acid synthesis, ribosomal biogenesis, metabolic reprogramming to support rapid cancer cell growth and survival, metastasis and invasion, and angiogenesis. mTORC2 has different subcellular localization and phosphorylates and activates AGC kinase family members, including AKT at Ser473 (AKT-pSer473), SGK, and PKC in response to upstream signals such as IGF1. Similar to mTORC1, PI3K acts as a critical regulator of mTORC2 by inducing the binding of mTORC2 to the ribosome. mTOR, mammalian/mechanistic target of rapamycin; PI3K, phosphatidylinositol 3-kinase; RAPTOR, Regulatory associated protein of mTOR; PRAS40, Proline-rich AKT substrate 40ku; mLST8, Mammalian LST8, also called G protein b-subunit like protein; DEPTOR, DEP domain-containing-mTOR interacting protein; Tel2, Telomere maintenance 2; Tti1, Tel2-interacting protein 1; RICTOR, Rapamycin insensitive companion of mTOR; mSIN1, mitogen-activated protein kinase-associated protein 1; PROTOR, Protein observed with Rictor; SGK, serum glucose kinase; PKC, protein kinase C; IGF1; Insulin-like growth factor 1; AMPK, AMP-activated protein kinase; REDD1, regulated in development and DNA damage response 1; HIF-1α, hypoxia-inducible factor-1α; VEGF, vascular endothelial growth factor; PTEN, phosphatase and tensin homolog deleted on chromosome 10; NF-κB, nuclear factor-κB; ULK1, UNC-51-like kinase 1; 4E-BP1, initiation factor 4E-binding protein 1; RHEB, Ras homolog enriched in brain; TSC1 and TSC2, tuberous sclerosis proteins 1 and 2; GSK3β, glycogen synthase kinase 3β; MMP, matrix metallopeptidase; FKBP12, FK506-binding protein; PIP2, phosphatidylinositol 4,5 biphosphate; PDK1, phosphoinositol-dependent-kinase; PtdIns(3,4,5)P3, Phosphatidylinositol (3,4,5)-trisphosphate.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig. S1 from The mTOR Signaling Pathway Interacts with the ER Stress Response and the Unfolded Protein Response in Cancer
Supplementary Fig. S1. The structure of mTOR complexes and overview of the PI3K/AKT/mTOR signaling pathway. The mTOR signaling pathway is implicated in a variety of major cellular processes, from cell growth to apoptosis. mTOR nucleates at least two distinct multi-protein complexes, mTORC1 and mTORC2. mTORC1 activation occurs in the response of growth factors through PI3K/Akt and RAS/MAPK pathways. Human mTOR can assemble at least two larges, physically, and functionally distinct polyprotein complexes, mTORC1, and mTORC2. mTORC1 and mTORC2 share several common proteins, including the catalytic subunit mTOR, mLST8 and DEPTOR, and Tel2/Tti1 complex. In addition, each complex has specific proteins. The activity of mTORC1 is regulated by multiple signals, including nutrient availability such as amino acids (leucine, arginine, and glutamine), intracellular energy level (Low ATP/High AMP), and extracellular growth factors such as insulin and cytokine receptors. A receptor-mediated activation of PI3K leads to PIP3 being produced from PIP2. PIP3 then promoted the recruitment of PDK1, AKT, and mTORC2 complex, facilitating the phosphorylation and full activation of AKT at Thr308 and Ser473 via PDK1 and mTORC2, respectively. Activated AKT phosphorylates TSC2 and induces the dissociation of TSC1 and TSC2 complex, which results in the dissociation of TSC2 from lysosomes and loss of their inhibitory action on RHEB/mTORC1 axis. Upon activation, mTOC1 promotes basic cellular events, including Cap-dependent translation, fatty acid synthesis, nucleoid acid synthesis, ribosomal biogenesis, metabolic reprogramming to support rapid cancer cell growth and survival, metastasis and invasion, and angiogenesis. mTORC2 has different subcellular localization and phosphorylates and activates AGC kinase family members, including AKT at Ser473 (AKT-pSer473), SGK, and PKC in response to upstream signals such as IGF1. Similar to mTORC1, PI3K acts as a critical regulator of mTORC2 by inducing the binding of mTORC2 to the ribosome. mTOR, mammalian/mechanistic target of rapamycin; PI3K, phosphatidylinositol 3-kinase; RAPTOR, Regulatory associated protein of mTOR; PRAS40, Proline-rich AKT substrate 40ku; mLST8, Mammalian LST8, also called G protein b-subunit like protein; DEPTOR, DEP domain-containing-mTOR interacting protein; Tel2, Telomere maintenance 2; Tti1, Tel2-interacting protein 1; RICTOR, Rapamycin insensitive companion of mTOR; mSIN1, mitogen-activated protein kinase-associated protein 1; PROTOR, Protein observed with Rictor; SGK, serum glucose kinase; PKC, protein kinase C; IGF1; Insulin-like growth factor 1; AMPK, AMP-activated protein kinase; REDD1, regulated in development and DNA damage response 1; HIF-1α, hypoxia-inducible factor-1α; VEGF, vascular endothelial growth factor; PTEN, phosphatase and tensin homolog deleted on chromosome 10; NF-κB, nuclear factor-κB; ULK1, UNC-51-like kinase 1; 4E-BP1, initiation factor 4E-binding protein 1; RHEB, Ras homolog enriched in brain; TSC1 and TSC2, tuberous sclerosis proteins 1 and 2; GSK3β, glycogen synthase kinase 3β; MMP, matrix metallopeptidase; FKBP12, FK506-binding protein; PIP2, phosphatidylinositol 4,5 biphosphate; PDK1, phosphoinositol-dependent-kinase; PtdIns(3,4,5)P3, Phosphatidylinositol (3,4,5)-trisphosphate.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Fig. S2 from The mTOR Signaling Pathway Interacts with the ER Stress Response and the Unfolded Protein Response in Cancer
Supplementary Fig. S2. Endoplasmic reticulum stress and unfolded protein response in normal physiology and cancer Tumor cells frequently encounter endogenous and exogenous stresses that influence protein folding in the ER, including hypoxia, inflammation, nutrient deprivation, altered glycolysis, DNA damage, genomic instability, oncogene activation, and proteasome dysfunction, can cause excessive accumulation of misfolded or unfolded proteins within the ER lumen, a condition termed "ER stress." As a response to prolonged ER stress conditions, the ER responds to the ER stress by activating intracellular signal transduction pathways, collectively referred to as the UPR, to restore-ER homeostasis (protective effect) or activate cell death (cytotoxic effect). The UPR signaling cascade comprises three parallel pathways that employ unique signal transduction mechanisms and are initiated by activating three conserved ER-stress sensors: IRE1, ATF6, and PERK. Furthermore, in mammals and under resting conditions, the critical ER-resident chaperone, GRP78/BiP, prevents the activation and blocks the downstream signaling of UPR by binding to the N-terminal side of stress sensor proteins, IRE-1, PERK, and ATF6 and maintains these sensors in an inactive state. When ER stress is triggered, and the ER luminal load of unfolded or misfolded proteins increases, the GRP78/BiP dissociates, activating IRE1, PERK, and ATF6 signaling cascades, leading to the activation of these UPR signaling pathways. Upon activation, the UPR can regulate many cellular events of tumor cells, including autophagy, ER biogenesis, cell survival, metastasis, angiogenesis, migration and invasion, chemoresistance, glycolysis, and proliferation. ER, Endoplasmic reticulum; UPR, unfolded protein response; PREK, protein kinase R (PKR) like endoplasmic reticulum kinase; ATF, activating transcription factor; IRE1, inositol requiring enzyme 1; GRP78, 78-kDa glucose-regulated protein/immunoglobulin-binding protein; CHOP, C/EBP homologous protein; AMPK, AMP-activated protein kinase; XBP-1, X-box binding protein 1; Dr5, death receptor 5; GADD34, growth arrest and DNA damage-inducible protein 34; ERO1α, ER oxidoreductin 1; GCN2, general control non-derepressible 2.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig. S2 from The mTOR Signaling Pathway Interacts with the ER Stress Response and the Unfolded Protein Response in Cancer
Supplementary Fig. S2. Endoplasmic reticulum stress and unfolded protein response in normal physiology and cancer Tumor cells frequently encounter endogenous and exogenous stresses that influence protein folding in the ER, including hypoxia, inflammation, nutrient deprivation, altered glycolysis, DNA damage, genomic instability, oncogene activation, and proteasome dysfunction, can cause excessive accumulation of misfolded or unfolded proteins within the ER lumen, a condition termed "ER stress." As a response to prolonged ER stress conditions, the ER responds to the ER stress by activating intracellular signal transduction pathways, collectively referred to as the UPR, to restore-ER homeostasis (protective effect) or activate cell death (cytotoxic effect). The UPR signaling cascade comprises three parallel pathways that employ unique signal transduction mechanisms and are initiated by activating three conserved ER-stress sensors: IRE1, ATF6, and PERK. Furthermore, in mammals and under resting conditions, the critical ER-resident chaperone, GRP78/BiP, prevents the activation and blocks the downstream signaling of UPR by binding to the N-terminal side of stress sensor proteins, IRE-1, PERK, and ATF6 and maintains these sensors in an inactive state. When ER stress is triggered, and the ER luminal load of unfolded or misfolded proteins increases, the GRP78/BiP dissociates, activating IRE1, PERK, and ATF6 signaling cascades, leading to the activation of these UPR signaling pathways. Upon activation, the UPR can regulate many cellular events of tumor cells, including autophagy, ER biogenesis, cell survival, metastasis, angiogenesis, migration and invasion, chemoresistance, glycolysis, and proliferation. ER, Endoplasmic reticulum; UPR, unfolded protein response; PREK, protein kinase R (PKR) like endoplasmic reticulum kinase; ATF, activating transcription factor; IRE1, inositol requiring enzyme 1; GRP78, 78-kDa glucose-regulated protein/immunoglobulin-binding protein; CHOP, C/EBP homologous protein; AMPK, AMP-activated protein kinase; XBP-1, X-box binding protein 1; Dr5, death receptor 5; GADD34, growth arrest and DNA damage-inducible protein 34; ERO1α, ER oxidoreductin 1; GCN2, general control non-derepressible 2.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Fig. S2 from The mTOR Signaling Pathway Interacts with the ER Stress Response and the Unfolded Protein Response in Cancer
Supplementary Fig. S2. Endoplasmic reticulum stress and unfolded protein response in normal physiology and cancer Tumor cells frequently encounter endogenous and exogenous stresses that influence protein folding in the ER, including hypoxia, inflammation, nutrient deprivation, altered glycolysis, DNA damage, genomic instability, oncogene activation, and proteasome dysfunction, can cause excessive accumulation of misfolded or unfolded proteins within the ER lumen, a condition termed "ER stress." As a response to prolonged ER stress conditions, the ER responds to the ER stress by activating intracellular signal transduction pathways, collectively referred to as the UPR, to restore-ER homeostasis (protective effect) or activate cell death (cytotoxic effect). The UPR signaling cascade comprises three parallel pathways that employ unique signal transduction mechanisms and are initiated by activating three conserved ER-stress sensors: IRE1, ATF6, and PERK. Furthermore, in mammals and under resting conditions, the critical ER-resident chaperone, GRP78/BiP, prevents the activation and blocks the downstream signaling of UPR by binding to the N-terminal side of stress sensor proteins, IRE-1, PERK, and ATF6 and maintains these sensors in an inactive state. When ER stress is triggered, and the ER luminal load of unfolded or misfolded proteins increases, the GRP78/BiP dissociates, activating IRE1, PERK, and ATF6 signaling cascades, leading to the activation of these UPR signaling pathways. Upon activation, the UPR can regulate many cellular events of tumor cells, including autophagy, ER biogenesis, cell survival, metastasis, angiogenesis, migration and invasion, chemoresistance, glycolysis, and proliferation. ER, Endoplasmic reticulum; UPR, unfolded protein response; PREK, protein kinase R (PKR) like endoplasmic reticulum kinase; ATF, activating transcription factor; IRE1, inositol requiring enzyme 1; GRP78, 78-kDa glucose-regulated protein/immunoglobulin-binding protein; CHOP, C/EBP homologous protein; AMPK, AMP-activated protein kinase; XBP-1, X-box binding protein 1; Dr5, death receptor 5; GADD34, growth arrest and DNA damage-inducible protein 34; ERO1α, ER oxidoreductin 1; GCN2, general control non-derepressible 2.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig. S2 from The mTOR Signaling Pathway Interacts with the ER Stress Response and the Unfolded Protein Response in Cancer
Supplementary Fig. S2. Endoplasmic reticulum stress and unfolded protein response in normal physiology and cancer Tumor cells frequently encounter endogenous and exogenous stresses that influence protein folding in the ER, including hypoxia, inflammation, nutrient deprivation, altered glycolysis, DNA damage, genomic instability, oncogene activation, and proteasome dysfunction, can cause excessive accumulation of misfolded or unfolded proteins within the ER lumen, a condition termed "ER stress." As a response to prolonged ER stress conditions, the ER responds to the ER stress by activating intracellular signal transduction pathways, collectively referred to as the UPR, to restore-ER homeostasis (protective effect) or activate cell death (cytotoxic effect). The UPR signaling cascade comprises three parallel pathways that employ unique signal transduction mechanisms and are initiated by activating three conserved ER-stress sensors: IRE1, ATF6, and PERK. Furthermore, in mammals and under resting conditions, the critical ER-resident chaperone, GRP78/BiP, prevents the activation and blocks the downstream signaling of UPR by binding to the N-terminal side of stress sensor proteins, IRE-1, PERK, and ATF6 and maintains these sensors in an inactive state. When ER stress is triggered, and the ER luminal load of unfolded or misfolded proteins increases, the GRP78/BiP dissociates, activating IRE1, PERK, and ATF6 signaling cascades, leading to the activation of these UPR signaling pathways. Upon activation, the UPR can regulate many cellular events of tumor cells, including autophagy, ER biogenesis, cell survival, metastasis, angiogenesis, migration and invasion, chemoresistance, glycolysis, and proliferation. ER, Endoplasmic reticulum; UPR, unfolded protein response; PREK, protein kinase R (PKR) like endoplasmic reticulum kinase; ATF, activating transcription factor; IRE1, inositol requiring enzyme 1; GRP78, 78-kDa glucose-regulated protein/immunoglobulin-binding protein; CHOP, C/EBP homologous protein; AMPK, AMP-activated protein kinase; XBP-1, X-box binding protein 1; Dr5, death receptor 5; GADD34, growth arrest and DNA damage-inducible protein 34; ERO1α, ER oxidoreductin 1; GCN2, general control non-derepressible 2.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Fig. S1 from The mTOR Signaling Pathway Interacts with the ER Stress Response and the Unfolded Protein Response in Cancer
Supplementary Fig. S1. The structure of mTOR complexes and overview of the PI3K/AKT/mTOR signaling pathway. The mTOR signaling pathway is implicated in a variety of major cellular processes, from cell growth to apoptosis. mTOR nucleates at least two distinct multi-protein complexes, mTORC1 and mTORC2. mTORC1 activation occurs in the response of growth factors through PI3K/Akt and RAS/MAPK pathways. Human mTOR can assemble at least two larges, physically, and functionally distinct polyprotein complexes, mTORC1, and mTORC2. mTORC1 and mTORC2 share several common proteins, including the catalytic subunit mTOR, mLST8 and DEPTOR, and Tel2/Tti1 complex. In addition, each complex has specific proteins. The activity of mTORC1 is regulated by multiple signals, including nutrient availability such as amino acids (leucine, arginine, and glutamine), intracellular energy level (Low ATP/High AMP), and extracellular growth factors such as insulin and cytokine receptors. A receptor-mediated activation of PI3K leads to PIP3 being produced from PIP2. PIP3 then promoted the recruitment of PDK1, AKT, and mTORC2 complex, facilitating the phosphorylation and full activation of AKT at Thr308 and Ser473 via PDK1 and mTORC2, respectively. Activated AKT phosphorylates TSC2 and induces the dissociation of TSC1 and TSC2 complex, which results in the dissociation of TSC2 from lysosomes and loss of their inhibitory action on RHEB/mTORC1 axis. Upon activation, mTOC1 promotes basic cellular events, including Cap-dependent translation, fatty acid synthesis, nucleoid acid synthesis, ribosomal biogenesis, metabolic reprogramming to support rapid cancer cell growth and survival, metastasis and invasion, and angiogenesis. mTORC2 has different subcellular localization and phosphorylates and activates AGC kinase family members, including AKT at Ser473 (AKT-pSer473), SGK, and PKC in response to upstream signals such as IGF1. Similar to mTORC1, PI3K acts as a critical regulator of mTORC2 by inducing the binding of mTORC2 to the ribosome. mTOR, mammalian/mechanistic target of rapamycin; PI3K, phosphatidylinositol 3-kinase; RAPTOR, Regulatory associated protein of mTOR; PRAS40, Proline-rich AKT substrate 40ku; mLST8, Mammalian LST8, also called G protein b-subunit like protein; DEPTOR, DEP domain-containing-mTOR interacting protein; Tel2, Telomere maintenance 2; Tti1, Tel2-interacting protein 1; RICTOR, Rapamycin insensitive companion of mTOR; mSIN1, mitogen-activated protein kinase-associated protein 1; PROTOR, Protein observed with Rictor; SGK, serum glucose kinase; PKC, protein kinase C; IGF1; Insulin-like growth factor 1; AMPK, AMP-activated protein kinase; REDD1, regulated in development and DNA damage response 1; HIF-1α, hypoxia-inducible factor-1α; VEGF, vascular endothelial growth factor; PTEN, phosphatase and tensin homolog deleted on chromosome 10; NF-κB, nuclear factor-κB; ULK1, UNC-51-like kinase 1; 4E-BP1, initiation factor 4E-binding protein 1; RHEB, Ras homolog enriched in brain; TSC1 and TSC2, tuberous sclerosis proteins 1 and 2; GSK3β, glycogen synthase kinase 3β; MMP, matrix metallopeptidase; FKBP12, FK506-binding protein; PIP2, phosphatidylinositol 4,5 biphosphate; PDK1, phosphoinositol-dependent-kinase; PtdIns(3,4,5)P3, Phosphatidylinositol (3,4,5)-trisphosphate.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig. S1 from The mTOR Signaling Pathway Interacts with the ER Stress Response and the Unfolded Protein Response in Cancer
Supplementary Fig. S1. The structure of mTOR complexes and overview of the PI3K/AKT/mTOR signaling pathway. The mTOR signaling pathway is implicated in a variety of major cellular processes, from cell growth to apoptosis. mTOR nucleates at least two distinct multi-protein complexes, mTORC1 and mTORC2. mTORC1 activation occurs in the response of growth factors through PI3K/Akt and RAS/MAPK pathways. Human mTOR can assemble at least two larges, physically, and functionally distinct polyprotein complexes, mTORC1, and mTORC2. mTORC1 and mTORC2 share several common proteins, including the catalytic subunit mTOR, mLST8 and DEPTOR, and Tel2/Tti1 complex. In addition, each complex has specific proteins. The activity of mTORC1 is regulated by multiple signals, including nutrient availability such as amino acids (leucine, arginine, and glutamine), intracellular energy level (Low ATP/High AMP), and extracellular growth factors such as insulin and cytokine receptors. A receptor-mediated activation of PI3K leads to PIP3 being produced from PIP2. PIP3 then promoted the recruitment of PDK1, AKT, and mTORC2 complex, facilitating the phosphorylation and full activation of AKT at Thr308 and Ser473 via PDK1 and mTORC2, respectively. Activated AKT phosphorylates TSC2 and induces the dissociation of TSC1 and TSC2 complex, which results in the dissociation of TSC2 from lysosomes and loss of their inhibitory action on RHEB/mTORC1 axis. Upon activation, mTOC1 promotes basic cellular events, including Cap-dependent translation, fatty acid synthesis, nucleoid acid synthesis, ribosomal biogenesis, metabolic reprogramming to support rapid cancer cell growth and survival, metastasis and invasion, and angiogenesis. mTORC2 has different subcellular localization and phosphorylates and activates AGC kinase family members, including AKT at Ser473 (AKT-pSer473), SGK, and PKC in response to upstream signals such as IGF1. Similar to mTORC1, PI3K acts as a critical regulator of mTORC2 by inducing the binding of mTORC2 to the ribosome. mTOR, mammalian/mechanistic target of rapamycin; PI3K, phosphatidylinositol 3-kinase; RAPTOR, Regulatory associated protein of mTOR; PRAS40, Proline-rich AKT substrate 40ku; mLST8, Mammalian LST8, also called G protein b-subunit like protein; DEPTOR, DEP domain-containing-mTOR interacting protein; Tel2, Telomere maintenance 2; Tti1, Tel2-interacting protein 1; RICTOR, Rapamycin insensitive companion of mTOR; mSIN1, mitogen-activated protein kinase-associated protein 1; PROTOR, Protein observed with Rictor; SGK, serum glucose kinase; PKC, protein kinase C; IGF1; Insulin-like growth factor 1; AMPK, AMP-activated protein kinase; REDD1, regulated in development and DNA damage response 1; HIF-1α, hypoxia-inducible factor-1α; VEGF, vascular endothelial growth factor; PTEN, phosphatase and tensin homolog deleted on chromosome 10; NF-κB, nuclear factor-κB; ULK1, UNC-51-like kinase 1; 4E-BP1, initiation factor 4E-binding protein 1; RHEB, Ras homolog enriched in brain; TSC1 and TSC2, tuberous sclerosis proteins 1 and 2; GSK3β, glycogen synthase kinase 3β; MMP, matrix metallopeptidase; FKBP12, FK506-binding protein; PIP2, phosphatidylinositol 4,5 biphosphate; PDK1, phosphoinositol-dependent-kinase; PtdIns(3,4,5)P3, Phosphatidylinositol (3,4,5)-trisphosphate.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Fig. S1 from The mTOR Signaling Pathway Interacts with the ER Stress Response and the Unfolded Protein Response in Cancer
Supplementary Fig. S1. The structure of mTOR complexes and overview of the PI3K/AKT/mTOR signaling pathway. The mTOR signaling pathway is implicated in a variety of major cellular processes, from cell growth to apoptosis. mTOR nucleates at least two distinct multi-protein complexes, mTORC1 and mTORC2. mTORC1 activation occurs in the response of growth factors through PI3K/Akt and RAS/MAPK pathways. Human mTOR can assemble at least two larges, physically, and functionally distinct polyprotein complexes, mTORC1, and mTORC2. mTORC1 and mTORC2 share several common proteins, including the catalytic subunit mTOR, mLST8 and DEPTOR, and Tel2/Tti1 complex. In addition, each complex has specific proteins. The activity of mTORC1 is regulated by multiple signals, including nutrient availability such as amino acids (leucine, arginine, and glutamine), intracellular energy level (Low ATP/High AMP), and extracellular growth factors such as insulin and cytokine receptors. A receptor-mediated activation of PI3K leads to PIP3 being produced from PIP2. PIP3 then promoted the recruitment of PDK1, AKT, and mTORC2 complex, facilitating the phosphorylation and full activation of AKT at Thr308 and Ser473 via PDK1 and mTORC2, respectively. Activated AKT phosphorylates TSC2 and induces the dissociation of TSC1 and TSC2 complex, which results in the dissociation of TSC2 from lysosomes and loss of their inhibitory action on RHEB/mTORC1 axis. Upon activation, mTOC1 promotes basic cellular events, including Cap-dependent translation, fatty acid synthesis, nucleoid acid synthesis, ribosomal biogenesis, metabolic reprogramming to support rapid cancer cell growth and survival, metastasis and invasion, and angiogenesis. mTORC2 has different subcellular localization and phosphorylates and activates AGC kinase family members, including AKT at Ser473 (AKT-pSer473), SGK, and PKC in response to upstream signals such as IGF1. Similar to mTORC1, PI3K acts as a critical regulator of mTORC2 by inducing the binding of mTORC2 to the ribosome. mTOR, mammalian/mechanistic target of rapamycin; PI3K, phosphatidylinositol 3-kinase; RAPTOR, Regulatory associated protein of mTOR; PRAS40, Proline-rich AKT substrate 40ku; mLST8, Mammalian LST8, also called G protein b-subunit like protein; DEPTOR, DEP domain-containing-mTOR interacting protein; Tel2, Telomere maintenance 2; Tti1, Tel2-interacting protein 1; RICTOR, Rapamycin insensitive companion of mTOR; mSIN1, mitogen-activated protein kinase-associated protein 1; PROTOR, Protein observed with Rictor; SGK, serum glucose kinase; PKC, protein kinase C; IGF1; Insulin-like growth factor 1; AMPK, AMP-activated protein kinase; REDD1, regulated in development and DNA damage response 1; HIF-1α, hypoxia-inducible factor-1α; VEGF, vascular endothelial growth factor; PTEN, phosphatase and tensin homolog deleted on chromosome 10; NF-κB, nuclear factor-κB; ULK1, UNC-51-like kinase 1; 4E-BP1, initiation factor 4E-binding protein 1; RHEB, Ras homolog enriched in brain; TSC1 and TSC2, tuberous sclerosis proteins 1 and 2; GSK3β, glycogen synthase kinase 3β; MMP, matrix metallopeptidase; FKBP12, FK506-binding protein; PIP2, phosphatidylinositol 4,5 biphosphate; PDK1, phosphoinositol-dependent-kinase; PtdIns(3,4,5)P3, Phosphatidylinositol (3,4,5)-trisphosphate.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig. S1 from The mTOR Signaling Pathway Interacts with the ER Stress Response and the Unfolded Protein Response in Cancer
Supplementary Fig. S1. The structure of mTOR complexes and overview of the PI3K/AKT/mTOR signaling pathway. The mTOR signaling pathway is implicated in a variety of major cellular processes, from cell growth to apoptosis. mTOR nucleates at least two distinct multi-protein complexes, mTORC1 and mTORC2. mTORC1 activation occurs in the response of growth factors through PI3K/Akt and RAS/MAPK pathways. Human mTOR can assemble at least two larges, physically, and functionally distinct polyprotein complexes, mTORC1, and mTORC2. mTORC1 and mTORC2 share several common proteins, including the catalytic subunit mTOR, mLST8 and DEPTOR, and Tel2/Tti1 complex. In addition, each complex has specific proteins. The activity of mTORC1 is regulated by multiple signals, including nutrient availability such as amino acids (leucine, arginine, and glutamine), intracellular energy level (Low ATP/High AMP), and extracellular growth factors such as insulin and cytokine receptors. A receptor-mediated activation of PI3K leads to PIP3 being produced from PIP2. PIP3 then promoted the recruitment of PDK1, AKT, and mTORC2 complex, facilitating the phosphorylation and full activation of AKT at Thr308 and Ser473 via PDK1 and mTORC2, respectively. Activated AKT phosphorylates TSC2 and induces the dissociation of TSC1 and TSC2 complex, which results in the dissociation of TSC2 from lysosomes and loss of their inhibitory action on RHEB/mTORC1 axis. Upon activation, mTOC1 promotes basic cellular events, including Cap-dependent translation, fatty acid synthesis, nucleoid acid synthesis, ribosomal biogenesis, metabolic reprogramming to support rapid cancer cell growth and survival, metastasis and invasion, and angiogenesis. mTORC2 has different subcellular localization and phosphorylates and activates AGC kinase family members, including AKT at Ser473 (AKT-pSer473), SGK, and PKC in response to upstream signals such as IGF1. Similar to mTORC1, PI3K acts as a critical regulator of mTORC2 by inducing the binding of mTORC2 to the ribosome. mTOR, mammalian/mechanistic target of rapamycin; PI3K, phosphatidylinositol 3-kinase; RAPTOR, Regulatory associated protein of mTOR; PRAS40, Proline-rich AKT substrate 40ku; mLST8, Mammalian LST8, also called G protein b-subunit like protein; DEPTOR, DEP domain-containing-mTOR interacting protein; Tel2, Telomere maintenance 2; Tti1, Tel2-interacting protein 1; RICTOR, Rapamycin insensitive companion of mTOR; mSIN1, mitogen-activated protein kinase-associated protein 1; PROTOR, Protein observed with Rictor; SGK, serum glucose kinase; PKC, protein kinase C; IGF1; Insulin-like growth factor 1; AMPK, AMP-activated protein kinase; REDD1, regulated in development and DNA damage response 1; HIF-1α, hypoxia-inducible factor-1α; VEGF, vascular endothelial growth factor; PTEN, phosphatase and tensin homolog deleted on chromosome 10; NF-κB, nuclear factor-κB; ULK1, UNC-51-like kinase 1; 4E-BP1, initiation factor 4E-binding protein 1; RHEB, Ras homolog enriched in brain; TSC1 and TSC2, tuberous sclerosis proteins 1 and 2; GSK3β, glycogen synthase kinase 3β; MMP, matrix metallopeptidase; FKBP12, FK506-binding protein; PIP2, phosphatidylinositol 4,5 biphosphate; PDK1, phosphoinositol-dependent-kinase; PtdIns(3,4,5)P3, Phosphatidylinositol (3,4,5)-trisphosphate.